Spyre Therapeutics, Inc. (SYRE) — SC 13G Filings
All SC 13G filings from Spyre Therapeutics, Inc.. Browse 5 Passive Stake Filing reports with AI-powered summaries and risk analysis.
SC 13G Filings (5)
- SC 13G Filing — Nov 8, 2024
- SC 13G Filing — Oct 23, 2024
- SC 13G Filing — Oct 22, 2024
- SC 13G Filing — Feb 14, 2024
-
FMR LLC & Abigail Johnson Disclose 7.97% Stake in Spyre Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its Chair and CEO, Abigail P. Johnson, have disclosed a significant stake in Spyre Therapeutics, Inc. (formerly Aeglea Bio
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX